Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 32 fibrosis PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


fibrosis PhD Projects, Programmes & Scholarships

We have 32 fibrosis PhD Projects, Programmes & Scholarships

Investigating the mechanisms for cardiac fibrosis development and reversal

Research interests/description of main research theme. Fibrosis is a hard to treat condition of major socioeconomic importance, with ~45% of all deaths in the developed world being attributed to some type of chronic fibro-proliferative disease and is exemplified by heart disease. Read more

Unravelling the biophysical mechanisms that regulate liver fibrosis

Applications are invited for a Postgraduate studentship, supported by the Engineering and Physical Sciences Research Council Doctoral Training Programme, to be undertaken within the College of Health and Life Sciences at Aston University. Read more

MSc by Research: Molecular characterisation of the factors driving lung fibrosis

Idiopathic pulmonary fibrosis (IPF) is a progressive disease that results in an irreversible decline in lung function.  At present IPF is normally fatal and the median survival is between 2 and 5 years after diagnosis. Read more

Preclinical testing of collagen synthesis inhibitors for fibrotic disease

Fibrotic disease is characterised by an excessive accumulation of collagen within tissues, which then impedes tissue function. Organ fibrosis specifically kidney fibrosis, liver fibrosis, cardiac fibrosis and lung fibrosis have limited treatment options, pose a huge clinical burden and are life-limiting diseases. Read more

Investigating mechanisms of extra-cellular matrix remodelling and fibrosis in the gastrointestinal tract

Inflammatory bowel diseases, such as Crohn's disease, are increasing in prevalence globally. These are caused by chronic inflammation in the gut, there is no cure and medications are not effective for all. Read more

Stress hormone metabolism – a novel anti-fibrotic therapeutic pathway for chronic wounds (Ref SHLS24121)

We have an exciting PhD opportunity within the Molecular Mechanisms of Long-term Conditions research group at Glasgow Caledonian University (https://www.gcu.ac.uk/aboutgcu/academicschools/hls/research/researchgroups/molecularmechanismsoflongtermconditions) to join the laboratory of Dr Catherine Wright with a supervisory team based in GCU and the University of Leeds. Read more

MScR: Cystic fibrosis: restoring ion transport with small molecules

Cystic fibrosis (CF) is caused by dysfunction of the cystic fibrosis transmembrane conductance regulator (CFTR), a unique ATP-binding cassette transporter that functions as an ATP-gated anion channel, playing a pivotal role in salt and water movement across epithelial tissues (1). Read more

Selective targeting of furin for the treatment of fibrotic lung disease.

Furin, a proprotein convertase has been established as a therapeutic target across several disease areas to include chronic airways diseases and infectious disease, such as COVID-19 (reviewed in our recent publication, Douglas et al, 2023). Read more

Development of Nanomaterials for Targeting the Bacteria–Host Interface in Cystic Fibrosis Airways

The attachment of Pseudomonas aeruginosa (PA) to the airway mucus in the lungs of people with cystic fibrosis (CF) represents an important step in airway colonization and the subsequent development of lung infection. Read more

Filtering Results